首页> 外文期刊>Clinica chimica acta: International journal of clinical chemistry and applied molecular biology >Assessing glomerular filtration rate in renal transplant recipients by estimates derived from serum measurements of creatinine and cystatin C.
【24h】

Assessing glomerular filtration rate in renal transplant recipients by estimates derived from serum measurements of creatinine and cystatin C.

机译:通过从肌酐和胱抑素C的血清测量得出的估计值评估肾移植受体的肾小球滤过率。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Assessing glomerular filtration rate (GFR) is of importance in the surveillance of renal transplant recipients. As serum markers alone are inaccurate for estimating GFR, several equations have been developed with the aim of translating a serum value into a corresponding and more accurate GFR. The present study investigated the diagnostic characteristics of GFR estimates obtained by the simplified MDRD formula and the cystatin C based estimate described by Larsson et al. METHODS: Prospective study in 29 stable renal transplant recipients. GFR was assessed with (125)I-Iothalamate clearance, creatinine was measured with a modified Jaffe method on Dimension RxL (Dade-Behring, Dudingen, Switzerland), cystatin C was determined by particle enhanced turbidimetric immunassay (PETIA; Dako, Glostrup, Denmark). Bias, precision and diagnostic accuracy of the two GFR estimates were assessed with Bland-Altman method and receiver-operating characteristics (ROC) analysis. The latter was performed at a GFR cut-off of 60 ml/min/1.73 m(2). RESULTS: The cystatin C based GFR estimate normalized to a body surface area of 1.73 m(2) exhibited a bias of -4.7 ml/min/1.73 m(2), the 95% limits of agreement were -25.5-16 ml/min/1.73 m(2) with an AUC of 0.87. The MDRD estimates obtained from the original creatinine revealed biased results. Thus, non-constant recalibration of creatinine was done. Recalibrated creatinine gave an MDRD GFR estimate with a bias of 1.7 ml/min/1.73 m(2). The limits of agreement were -23.1-26.4 ml/min/1.73 m(2). ROC analysis revealed an AUC 0.8 and was not significantly different from the cystatin C based GFR estimate. CONCLUSIONS: In renal transplant recipients, the cystatin C based GFR estimate exhibits similar diagnostic characteristics like the simplified MDRD formula. In contrast to cystatin C measurement, recalibration of creatinine might be necessary before implementing the simplified MDRD formula into clinical routine.
机译:背景:评估肾小球滤过率(GFR)在肾移植受者的监测中很重要。由于仅血清标志物不足以估计GFR,因此已开发了一些方程式,目的是将血清值转化为相应且更准确的GFR。本研究调查了由简化的MDRD公式获得的GFR估计值的诊断特征,以及Larsson等人描述的基于胱抑素C的估计值。方法:对29名稳定的肾移植受者进行了前瞻性研究。 GFR用(125)I-乙草酸酯清除率评估,肌酐用改良的Jaffe方法在Dimension RxL(Dade-Behring,Dudingen,瑞士)上测量,胱抑素C通过颗粒增强比浊免疫分析法(PETIA; Dako,Glstrup,丹麦)测定)。使用Bland-Altman方法和接收者操作特征(ROC)分析评估了两个GFR估计的偏差,精度和诊断准确性。后者以GFR截止值为60 ml / min / 1.73 m(2)进行。结果:标准化为1.73 m(2)的基于半胱氨​​酸蛋白酶抑制剂C的GFR估计值显示为-4.7 ml / min / 1.73 m(2)的偏差,协议的95%限制为-25.5-16 ml / min /1.73 m(2),AUC为0.87。从原始肌酐获得的MDRD估计值显示出偏差的结果。因此,进行了肌酐的非恒定重新校准。重新校准的肌酐给出了MDRD GFR估算值,偏差为1.7 ml / min / 1.73 m(2)。协议的限制为-23.1-26.4 ml / min / 1.73 m(2)。 ROC分析显示AUC为0.8,与基于半胱氨​​酸蛋白酶抑制剂C的GFR估算值无显着差异。结论:在肾移植受者中,基于半胱氨​​酸蛋白酶抑制剂C的GFR估算值具有类似的诊断特征,如简化的MDRD公式。与半胱氨酸蛋白酶抑制剂C的测量相反,在将简化的MDRD公式应用于临床常规之前,可能需要重新校准肌酐。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号